Megestrol - Daewon PharmaceuticalAlternative Names: DW-ES(A); DW-ES(B)
Latest Information Update: 23 May 2016
At a glance
- Originator Daewon Pharmaceutical
- Class Antiandrogens; Antineoplastics; Pregnadienes; Small molecules
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Anorexia; Cachexia
Most Recent Events
- 23 May 2016 Chemical information added
- 15 Mar 2016 Biomarkers information updated